Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

China Investor Syndicate Acquires Esaote, an Italian Imaging Device Company

publication date: Dec 8, 2017

Esaote S.p.A., an Italian medical imaging company, has been acquired by a group of China investors. The China syndicate was headed by Yunfeng Capital, Alibaba's investment arm, and joined by several China medical device makers and investment firms. The price was not disclosed. Esaote will continue as a standalone company headed by its current CEO, Karl-Heinz Lumpi. The China investors intend to introduce Esaote's products -- Ultrasound and MRI scanners, together with associated IT -- to the China market. The company produced $317 million of revenue in 2016. More details....

Stock Symbol: (NYSE: BABA)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.